EFFICACY AND SAFETY OF DUPILUMAB TREATMENT UP TO 1 YEAR IN INFANTS AND PRESCHOOL CHILDREN WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

被引：0
|
作者：
Cork, Michael J. [1 ,2 ]
Paller, Amy S. [3 ,4 ]
Siegfried, Elaine C. [1 ,2 ,5 ,6 ]
Xiao, Jing [7 ]
Prescilla, Randy [8 ]
Dubost-Brama, Ariane [9 ]
Bansal, Ashish [7 ]
机构：
[1] Univ Sheffield, Sheffield Dermatol Res, Sheffield, S Yorkshire, England
[2] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[4] Ann & Robert H Lurie Childrens Hosp, Chicago, IL USA
[5] St Louis Univ, St Louis, MO USA
[6] Cardinal Glennon Childrens Hosp, St Louis, MO USA
[7] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[8] Sanofi, Cambridge, MA USA
[9] Sanofi, Chilly Mazarin, France
来源：
ACTA DERMATO-VENEREOLOGICA | 2023年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P10.8
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [31] Dupilumab Treatment Reduces Hospitalizations in Adults With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan, I
    Rubini, Norma P. M.
    Pires, Mario C.
    Rossi, Ana B.
    Zhang, Annie
    Chen, Zhen
    Levit, Noah A.
    Chao, Jingdong
    Shumel, Brad
    Bego-Le Bagousse, Gaelle
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (05): : 1279 - +
  • [32] Efficacy and safety of long-term treatment with dupilumab for moderate to severe atopic dermatitis
    Ikeda, M.
    Uehara, H.
    Tsuge, M.
    ALLERGY, 2019, 74 : 182 - 182
  • [33] Comparison of Efficacy of Baricitinib and Dupilumab in the Treatment of Chinese Moderate-To-Severe Atopic Dermatitis: A Retrospective Study
    Liu, Bo
    Song, Xiaoting
    Liao, Shuanglu
    Luan, Tingting
    Zhao, Zuotao
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (10) : 966 - 974
  • [34] Efficacy and safety of upadacitinib in the treatment of moderate-to-severe atopic dermatitis: A systematic review
    Zhao, Dan-Jie
    Li, Xia
    Lin, Hai-Xia
    Zheng, Hong
    Zhou, Di
    Tang, Peng
    PLOS ONE, 2024, 19 (07):
  • [35] Efectiveness and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a 64-week follow-up study
    Lopez-Vinardell, L.
    Gras Martin, L.
    Garin Escriva, N.
    Riera Armengol, P.
    Serra Baldrich, E.
    Zurita Alonso, B.
    Mas Malagarriga, N.
    Conejo Marin, I.
    Masip Torne, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 279 - 279
  • [36] Efficacy and safety of dupilumab in Japanese adults with moderate-to-severe atopic dermatitis: a subanalysis of three clinical trials
    Katoh, N.
    Kataoka, Y.
    Saeki, H.
    Hide, M.
    Kabashima, K.
    Etoh, T.
    Igarashi, A.
    Imafuku, S.
    Kawashima, M.
    Ohtsuki, M.
    Fujita, H.
    Arima, K.
    Takagi, H.
    Chen, Z.
    Shumel, B.
    Ardeleanu, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (01) : 39 - 51
  • [37] Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
    Blauvelt, Andrew
    Teixeira, Henrique D.
    Simpson, Eric L.
    Costanzo, Antonio
    De Bruin-Weller, Marjolein
    Barbarot, Sebastien
    Prajapati, Vimal H.
    Lio, Peter
    Hu, Xiaofei
    Wu, Tianshuang
    Liu, John
    Ladizinski, Barry
    Chu, Alvina D.
    Eyerich, Kilian
    JAMA DERMATOLOGY, 2021, 157 (09) : 1047 - 1055
  • [38] Dupilumab treatment in children with moderate-to-severe atopic dermatitis increases levels of bone mineralization biomarkers
    Irvine, A. D.
    Paller, A.
    Horowitz, J. E.
    Farrell, A.
    Hatsell, S.
    Ehmann, P.
    Rodriguez Marco, A.
    Tian, T.
    Cyr, S. L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S110 - S110
  • [39] Efficacy and Safety of Upadacitinib versus Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Four Body Regions: Analysis from the Heads Up Study
    Thyssen, Jacob P.
    Rosmarin, David
    Costanzo, Antonio
    Warren, Richard
    Chu, Chia-Yu
    Chovatiya, Raj
    Ladizinski, Barry
    Hu, Xiaofei
    Liu, Yingyi
    Calimlim, Brian
    Nduaka, Chudi
    Vigna, Namita
    Armstrong, April
    DERMATOLOGY, 2025, 241 (01) : 10 - 18
  • [40] Dupilumab treatment in children with moderate-to-severe atopic dermatitis increases levels of bone mineralization biomarkers
    Irvine, Alan D.
    Paller, Amy S.
    Horowitz, Julie E.
    Farrell, Annamaria
    Hatsell, Sarah
    Ehmann, Peter
    McDonald, Robert
    Marco, Ainara Rodriguez
    Tian, Tingting
    Cyr, Sonya L.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
12345